このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Zydus Lifesciences バランスシートの健全性
財務の健全性 基準チェック /66
Zydus Lifesciencesの総株主資本は₹221.0B 、総負債は₹7.7Bで、負債比率は3.5%となります。総資産と総負債はそれぞれ₹292.8Bと₹71.8Bです。 Zydus Lifesciencesの EBIT は₹45.4Bで、利息カバレッジ比率55.9です。現金および短期投資は₹13.6Bです。
主要情報
3.5%
負債資本比率
₹7.69b
負債
インタレスト・カバレッジ・レシオ | 55.9x |
現金 | ₹13.58b |
エクイティ | ₹221.02b |
負債合計 | ₹71.79b |
総資産 | ₹292.81b |
財務の健全性に関する最新情報
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Jun 10Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Dec 27We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt
Jul 15Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly
Feb 15We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt
Nov 13Recent updates
Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
Jun 20Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Jun 10Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
May 25Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?
Mar 18Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%
Feb 28Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report
Feb 12Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Dec 27Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors
Dec 06With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case
Aug 23Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00
Jul 17We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt
Jul 15Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's
Jun 24Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00
Jun 10Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00
May 21Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly
Feb 15We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt
Nov 13Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Shares Could Be 23% Below Their Intrinsic Value Estimate
Aug 09Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 25Zydus Lifesciences (NSE:ZYDUSLIFE) Has Announced That Its Dividend Will Be Reduced To ₹2.50
Jul 10財務状況分析
短期負債: ZYDUSLIFEの 短期資産 ( ₹115.0B ) が 短期負債 ( ₹53.4B ) を超えています。
長期負債: ZYDUSLIFEの短期資産 ( ₹115.0B ) が 長期負債 ( ₹18.4B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: ZYDUSLIFE総負債よりも多くの現金を保有しています。
負債の削減: ZYDUSLIFEの負債対資本比率は、過去 5 年間で67.9%から3.5%に減少しました。
債務返済能力: ZYDUSLIFEの負債は 営業キャッシュフロー によって 十分にカバー されています ( 420% )。
インタレストカバレッジ: ZYDUSLIFEの負債に対する 利息支払い は EBIT ( 55.9 x coverage) によって 十分にカバーされています。